Oxidized low-density lipoprotein biomarkers in atherosclerosis

被引：77

作者：

Tsimikas S. ^{[1
]}

机构：

[1] Vascular Medicine Program, University of California San Diego, La Jolla, CA 92037-0975

来源：

Current Atherosclerosis Reports | 2006年 / 8卷 / 1期

关键词：

Arterioscler Thromb Vasc Biol; oxLDL Level; Soluble Immune Complex; Cholesteryl Linoleate; Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering;

D O I：

10.1007/s11883-006-0065-1

中图分类号：

学科分类号：

摘要：

The concept that the oxidation of lipoproteins is central in the pathogenesis of atherosclerosis was first reported over 25 years ago, initially by in vitro studies and subsequently through experimental models of atherosclerosis. The innate immune system plays a key role in atherogenesis as manifested by its atherosclerosis-modulating properties, the immunogenicity of oxidized low-density lipoprotein (LDL), and the presence of oxidized LDL autoantibodies in plasma and lesions of humans. In the past 10 years it has been possible to generate monoclonal antibodies to oxidized LDL to directly measure oxidized LDL in plasma. This has led to a rapidly accelerating pace of new reports on the relationship of circulating oxidized LDL and various cardiovascular pathologic processes, which are the focus of this review. Copyright © 2006 by Current Science Inc.

引用

页码：55 / 61

页数：6

共 53 条

[1]

Tsimikas S., Glass C., Steinberg D., Witztum J.L., Lipoproteins, lipoprotein oxidation and atherogenesis, Molecular Basis of Cardiovascular Disease. A Companion to Braunwald's Heart Disease, pp. 385-413, (2004)

[2]

Navab M., Ananthramaiah G.M., Reddy S.T., Et al., Thematic review series: The pathogenesis of atherosclerosis: The oxidation hypothesis of atherogenesis: The role of oxidized phospholipids and HDL, J Lipid Res, 45, pp. 993-1007, (2004)

[3]

Tsimikas S., Witztum J.L., Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk, Circulation, 103, pp. 1930-1932, (2001)

[4]

Libby P., Inflammation in atherosclerosis, Nature, 420, pp. 868-874, (2002)

[5]

Palinski W., Napoli C., The fetal origins of atherosclerosis: Maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis, FASEB J, 16, pp. 1348-1360, (2002)

[6]

Tsimikas S., Palinski W., Halpern S.E., Et al., Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo, J Nucl Cardiol, 6, pp. 41-53, (1999)

[7]

Torzewski M., Shaw P.X., Han K.R., Et al., Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization Arterioscler, Thromb Vasc Biol, 24, pp. 2307-2312, (2004)

[8]

Ehara S., Ueda M., Naruko T., Et al., Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes, Circulation, 103, pp. 1955-1960, (2001)

[9]

Nishi K., Itabe H., Uno M., Et al., Oxidized LDL in carotid plaques and plasma associates with plaque instability, Arterioscler Thromb Vasc Biol, 22, pp. 1649-1654, (2002)

[10]

Tsimikas S., Shortal B.P., Witztum J.L., Palinski W., In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression, Arterioscler Thromb Vasc Biol, 20, pp. 689-697, (2000)

← 1 2 3 4 5 6 →